Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea
Phase 3
Completed
- Conditions
- Facial Rosacea
- Interventions
- First Posted Date
- 2019-09-27
- Last Posted Date
- 2020-10-14
- Lead Sponsor
- Zydus Worldwide DMCC
- Target Recruit Count
- 525
- Registration Number
- NCT04106726
- Locations
- 🇺🇸
Zydus Worldwide DMCC, El Paso, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath